The inhibition of HIV-1’s replicative machinery remains a cornerstone in the battle against AIDS. Central to this approach are inhibitors targeting reverse transcriptase (RT) and integrase. Reverse ...
Globally, in 2020, 38 million people were living with HIV with an additional 1.5 million newly infected. During this period, 73% of those living with HIV were accessing antiretroviral therapy (WHO HIV ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research ...
In a discovery that could spur the development of new therapies for more than 40 million HIV patients worldwide, scientists from Rutgers University and the Salk Institute determined the molecular ...
Globally, in 2020, 38 million people were living with HIV with an additional 1.5 million newly infected. During this period, 73% of those living with HIV were accessing antiretroviral therapy (WHO HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback